KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 148 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 1.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $442,386 | +27.7% | 113,724 | +11.6% | 0.00% | 0.0% |
| Q4 2022 | $346,518 | -19.2% | 101,917 | +29.6% | 0.00% | 0.0% |
| Q3 2022 | $429,000 | +410.7% | 78,657 | +321.1% | 0.00% | – |
| Q2 2022 | $84,000 | -39.1% | 18,680 | 0.0% | 0.00% | -100.0% |
| Q1 2022 | $138,000 | -50.9% | 18,680 | +27.9% | 0.00% | -50.0% |
| Q1 2020 | $281,000 | +20.6% | 14,610 | +20.4% | 0.00% | +100.0% |
| Q4 2019 | $233,000 | -63.9% | 12,130 | -82.4% | 0.00% | -75.0% |
| Q4 2018 | $645,000 | -5.6% | 68,835 | +71.7% | 0.00% | 0.0% |
| Q3 2018 | $683,000 | +21.1% | 40,090 | +20.9% | 0.00% | +33.3% |
| Q2 2018 | $564,000 | – | 33,170 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Consonance Capital Management LP | 7,180,700 | $137,941,000 | 10.27% |
| Palo Alto Investors LP | 4,299,901 | $82,601,000 | 6.92% |
| Fairmount Funds Management LLC | 562,351 | $10,803,000 | 6.55% |
| Avoro Capital Advisors LLC | 7,000,000 | $134,470,000 | 4.54% |
| Pinz Capital Management, LP | 8,820 | $1,694,000 | 4.44% |
| Birchview Capital, LP | 148,000 | $2,843,000 | 2.52% |
| Elk Creek Partners, LLC | 699,951 | $13,446,000 | 2.31% |
| Parkman Healthcare Partners LLC | 215,802 | $4,146,000 | 1.92% |
| EAM Global Investors LLC | 136,402 | $2,620,000 | 1.53% |
| SPHERA FUNDS MANAGEMENT LTD. | 550,000 | $10,566,000 | 1.32% |